ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Contact

MRI

  • Home
  • MRI
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results
  • All
  • Anal cancer
  • Breast cancer
  • Caregiving
  • Chemotherapy
  • Chronic lymphocytic leukemia
  • De-escalation
  • HER2+ breast cancer
  • Hormone therapy
  • Immune system therapy
  • Immunotherapy
  • In memory
  • Kidney cancer
  • Late Effects
  • Leukemia
  • Lymphoma
  • Mammography
  • Mantle cell lymphoma
  • Melanoma
  • MRI
  • Neuropathy
  • Pancreatic cancer
  • Pancreatic cysts
  • Personalized medicine
  • Personalized screening
  • Prevention
  • Renal cell carcinoma
  • Screening
  • Side effects
  • Squamous cell carcinoma
  • Surveillance
  • Survivorship
  • Targeted therapy
  • Throat cancer
  • Triple-negative breast cancer
  • Tumor test
  • All
  • Akshay Hanikhindi
  • Diane Dragaud
  • ecogacrinnews2
  • Katie Heller
  • wpengine
October 2, 2020
October 2, 2020
Categories
  • Trial Results

Trial Results: A 10-minute MRI proves useful in women with dense breasts at average risk of developing breast cancer

Dr. Christopher Comstock, a radiologist who specializes in breast cancer imaging, talks about the results of clinical trial EA1141 and how it will hopefully give far more women access to a powerful tool in the fight against breast cancer
Do you like it?
0 Read more

Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2012-2019 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc